South Dakota School of Mines & Technology Invites Business Investment in New Generation Battery Technology During Conference


https://www.prweb.com/

Dr. Alevtina Smirnova

“Solid-state is the future of energy storage,” says Dr. Alevtina Smirnova, an associate professor of chemistry and applied biological sciences and electrical and computer engineering at SD Mines.

Research scientists at South Dakota School of Mines & Technology will host hundreds of industry representatives, the National Science Foundation (NSF) and fellow academics on Thursday and Friday, Sept. 12-13, in a bid to establish an international center to develop solid-state batteries which will be safer, cheaper, smaller and more efficient than lithium ion batteries.

The center would be a huge economic boost to both SD Mines as well as the state of South Dakota, says Dr. Alevtina Smirnova, an associate professor of chemistry and applied biological sciences and electrical and computer engineering at Mines.

Smirnova and research scientist Dr. Abu Md “Numan” Numan-Al-Mobin are leading the grant proposal to NSF for the establishment of the Center for Green Solid-State Electric Power Generation and Storage(CEPS). Smirnova and Numan are responsible for the coordination of the Sept. 12-13 conference.

“We are excited about the possibility of Mines taking such a major role in new green technology that could really change the world,” Smirnova says. “We hope CEPS will become the center for development of eco-friendly, safe and economically feasible all-solid-state energy storage technology.”

Smirnova says the solid batteries developed in CEPS would be ideal for portable and medical applications, the automotive industry, centralized and decentralized electric grids, military applications and energy security.

Some of the industry leaders attending the conference include Ford (attending remotely), Swiss company LafargeHolcim, Garmin International, Caterpillar Inc., Naval Air Systems Command, Solvay of Belgium, Collins Aerospace, L3Harris Technologies, 3M and Parker-Hannifin Corporation.

The push to find safer, more sustainable batteries is the “holy grail” right now, Smirnova says.

“The reality is, conventional lithium-ion batteries are not safe or reliable.” Conventional batteries contain a liquid, that renders them flammable, dangerous and costly. In 2016, the lithium ion batteries in Samsung’s Galaxy Note 7 computers cost the company $10 billion when many of the batteries exploded.

This week’s conference is the second step in the process to bring CEPS to its fully-funded fruition. Smirnova was awarded a $60,000 NSF planning grant in January to create an Industry/University Cooperative Research Center (IUCRC) on campus. With SD Mines as the lead center, three other universities became “sites” to work on specific pieces of the research needed to make solid-state batteries a reality. Those universities are South Dakota State University in Brookings, University of South Dakota in Vermillion and Northeastern University in Massachusetts. Each university received $15,000 of the planning grant.

Under the NSF grant process, Mines and the three sites must now secure three business partnerships with companies, with each company contributing $50,000. NSF will match the $50,000 for the first three partners up to $600,000 per year. NSF also requires Mines and each site to partner with national labs for research assistance.

The NSF program strives to create cooperative research centers that create long-term partnerships among industry, academia and government.

The $50,000 investment by industry will give them a seat at the CEPS Industry Advisory Board, a vote in the CEPS research and development portfolio, the ability to monitor progress in the development of the technology, involvement in the development and approval of CEPS’ bylaws and the retainment of non-exclusive licenses to develop products. They will also be helping to train students for future employment, supporting the economic development of South Dakota and supporting sustainable electric power grids, Smirnova says.

NSF will evaluate CEPS’ progress during the conference this week. If the requirements are in place and CEPS can show it can attract members from industry, Smirnova will be asked to submit a full grant in December, requesting $600,000 per year for 5 years in grant funding for the project. The funds must be matched 1:1 by industry.

If NSF approves CEPS for full funding, the center and its three sites will have 10 to 15 years to become self-sustaining.

“We welcome these companies to our campus and look forward to sharing this exciting research with them,” Smirnova says. “Solid-state is the future of energy storage.”

Share article on social media or email:



Source link

Medigap Premiums Grew More Than Twice the Rate of the Social Security COLA Over Past Year — Forecast Worse for Next Year According to The Senior Citizens League


https://www.prweb.com/

Mary Johnson

“Inflation is lower this year, and we are estimating that the COLA is likely to be around 1.7 percent,” Johnson says. “Nevertheless, we anticipate that Medigap premiums will continue to grow several times faster for a number of reasons,” Johnson adds.

According to a new survey by The Senior Citizens League (TSCL), premiums for Medicare supplemental insurance, known as Medigap, grew more than twice as fast as Social Security cost – of – living -adjustments (COLA) in the past year. About 41 percent of survey participants who are covered by a Medigap policy report robust premium increases in the past 12 months of at least 6 percent or more, particularly for individuals who were covered by a policy for more than two years. “The Social Security COLA for 2019 is 2.8 percent, far lower than the rate that Medigap policies appear to be growing,” says Mary Johnson, a Social Security and Medicare policy analyst for The Senior Citizens League.

In addition to rapidly growing Medigap premiums, retirees also must pay for premiums for Medicare Part B and their drug plans. The combination takes a bigger bite out of Social Security benefits and other retirement resources when COLAs fail to keep pace. “The financial drain on benefits is difficult to anticipate, and many retirees don’t have adequate savings to begin with,” Johnson says.    

The disparity between growth in the COLA and Medigap premiums is likely to be worse in 2020. “Inflation is lower this year, and we are estimating that the COLA is likely to be around 1.7 percent,” Johnson says. “Nevertheless, we anticipate that Medigap premiums will continue to grow several times faster for a number of reasons,” Johnson adds.

Two of the most popular Medigap plans, “F” and “C,” will no longer be offered for sale in 2020. “While individuals enrolled in these plans may keep their plans, we are concerned that premiums for these plans could rise significantly without younger and healthier new enrollees to spread the costs in those plans,” Johnson says.

In 2019, there are a total of ten different Medigap plans, “A” through “N.” Congress closed Plans “F” and “C” because they cover the Medicare Part B deductible. The thinking is that deductibles prevent “over utilization” of Medicare benefits. The Part B deductible is $135.50 this year and it rises at the same pace as the Part B premium. According to research by Johnson, Part B premiums have increased about 10 percent per year since 2000, making it one of the fastest growing costs in retirement. “Requiring retirees to pay deductibles, or higher deductibles, has the biggest financial and health impact on middle-income Medicare beneficiaries with modest means,” says Johnson. “Many put off medically necessary care if they can’t afford the deductible, and their health can get worse when they do,” she says.

About one quarter of all Medicare beneficiaries are covered by Medigap polices. Out-of-pocket costs under Medicare are considerable, and most beneficiaries supplement their coverage either by purchasing a Medigap policy or joining a Medicare Advantage plan. Unlike Medicare Advantage, however, Medigap enrollees in most states are not able to switch to another Medigap policy during fall open enrollment, because insurers are not required to cover pre-existing conditions outside of the individual’s initial enrollment period. Seventy-two percent of survey participants support extending guaranteed coverage for pre-existing conditions to Medigap, allowing Medigap enrollees greater freedom to switch to other, less costly, Medigap plans.

The Senior Citizens League supports legislation that protects Medicare benefits and lowers out-of-pocket costs for beneficiaries. To learn how to get involved, visit http://www.SeniorsLeague.org.

With 1.2 million supporters, The Senior Citizens League is one of the nation’s largest nonpartisan seniors’ groups. Its mission is to promote and assist members and supporters, to educate and alert senior citizens about their rights and freedoms as U.S. Citizens, and to protect and defend the benefits senior citizens have earned and paid for. The Senior Citizens League is a proud affiliate of The Retired Enlisted Association. Visit http://www.SeniorsLeague.org for more information.

Share article on social media or email:



Source link

UAB Expands Use of Virtual Care Technology


The University of Alabama at Birmingham Health System has expanded its use of a digital application for patients undergoing colorectal, gynecologic oncology, cardiac and thoracic surgeries.

SeamlessMD, a platform for patient engagement, remote monitoring and virtual care, was implemented in 2017 as a part of UAB’s Enhanced Recovery After Surgery initiative, which began with colorectal surgery. The ERAS program is a patient-centered approach to integrate evidence-based interventions across the entire surgical pathway, leading to better patient satisfaction and health outcomes.

“Surgery is often a confusing and overwhelming process for patients,” said Daniel Chu, M.D., UAB’s ERAS medical director and associate professor in the Department of Surgery. “Our patients can stay connected on their desktops, laptops and mobile devices with SeamlessMD so they are engaged with the recovery process both before and after surgery.”

With this expansion, UAB now provides a digital experience that guides more patients from surgery preparation through recovery. Patients can access the digital application through their mobile phone, tablet or computer, and they receive reminders to help them follow the ERAS care plan. Patients can also access an education library to learn about what to expect from their surgery and the recovery process. Upon discharge from the hospital, patients can report their pain scores, symptoms and wound photos from their own devices, enabling them to stay connected with the care team.

“The many unknowns around surgery can cause a lot of anxiety for patients and their families,” said Haller Smith, M.D., a fellow in the Department of Obstetrics and Gynecology. “We can help reduce that anxiety by providing easy access to information through a platform that helps patients prepare for surgery and to know what to expect when they get home. The daily health checks within the app are very helpful as they can either reassure a patient that their recovery is on track, or prompt them to contact their surgical team to flag issues that are outside of the norm, hopefully enabling us to catch any potential complications early.”

Trina Smith, lead certified registered nurse practitioner for the cardiovascular surgery clinic, wants to see how the technology will impact UAB’s cardiac program.

“We need tools to objectively assess how we can provide the highest standard of care,” she said. “Patient-reported outcomes and compliance data collected by the SeamlessMD platform will enable us to pinpoint where we need to focus our attention for quality improvement.”

In addition to patient engagement, UAB aims to increase patient compliance with ERAS protocols, which is correlated with faster recovery times. The UAB Health System will leverage the technology to deliver a standardized ERAS pathway, as well as personalized educational resources for each patient based on their unique medical profile.

“We are thrilled to partner with UAB to scale the platform across many departments within the UAB Health System, helping more patients and effecting positive change for the industry,” said SeamlessMD CEO Joshua Liu, M.D.

About UAB

Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham is an internationally renowned research university and academic medical center, as well as Alabama’s largest employer, with some 23,000 employees, and has an annual economic impact exceeding $7 billion on the state. The five pillars of UAB’s mission include education, research, patient care, community service and economic development. UAB is a two-time recipient of the prestigious Center for Translational Science Award. Learn more at http://www.uab.edu. UAB: Powered by will.

About SeamlessMD

SeamlessMD is the #1 platform for patient engagement, remote monitoring and virtual care used by leading health systems to engage, educate and track patients before, during and after a procedure. Evidence from academic medical centers has shown SeamlessMD to reduce hospital length of stay, readmissions, ER visits, SNF use and costs. The platform is accessible for patients via smartphone, tablet or computer, and keeps patients on track from preparation through recovery with reminders, multimedia education, progress tracking and Patient Reported Outcomes data collection. Providers can access real-time dashboards to measure compliance and outcomes, intervene sooner for patients at-risk and drive quality improvement across the organization. For more information, please visit: http://www.seamless.md.

Share article on social media or email:



Source link

Verge Genomics Appoints Jane Rhodes, Ph.D., M.B.A. as Chief Business Officer


“The addition of Jane to our leadership team reflects our growing commitment to partnerships that can maximize the utility of our platform for patients suffering from complex diseases,” said Alice Zhang, CEO and co-founder of Verge Genomics.

Verge Genomics, a biotechnology company utilizing human genomics to develop effective therapeutics for CNS disorders, today announced the appointment of Jane Rhodes, Ph.D., M.B.A. as its Chief Business Officer. In this role, Dr. Rhodes will lead the business and strategy functions and serve as a member of the Executive Leadership Team.

Dr. Rhodes brings more than 23 years of drug discovery, company building, and business strategy leadership in the biotechnology industry. Dr. Rhodes most recently served as Vice President of Business Development and Corporate Strategy at FORMA Therapeutics, where she spearheaded the establishment of an emerging neuro-therapeutic area through a network of strategic partnerships. Prior to that, Dr. Rhodes spent 18 years at Biogen, where she held positions of increasing responsibility across both scientific program leadership and new strategic initiatives with oversight for programs from pre-clinical through regulatory submission, approval and commercialization.

“The addition of Jane to our leadership team reflects our growing commitment to partnerships that can maximize the utility of our platform for patients suffering from complex diseases,” said Alice Zhang, CEO and co-founder of Verge Genomics. “Jane has a stellar record as both a neuroscientist and strategic business leader. Her cross-functional company building, drug hunting, and business experience will accelerate our vision of leveraging machine learning to more effectively bring medicines to patients in need.”

During her tenure at Biogen, Dr. Rhodes’ notable achievements include founding the Value Based Medicine (VBM) Innovation Hub. As Senior Director of New Initiatives, Dr. Rhodes led efforts to develop digital assessment tools that are now used as standard of care in neurology clinics across the US and Europe. This work prompted Dr. Rhodes to co-found Qr8 Health, a software development company pioneering the development of patient assessment tools for the measurement of neurological and motor function.

“Having witnessed the challenges of CNS drug development first-hand, I believe that the next breakthrough requires a truly bold approach,” said Dr. Rhodes. “As our understanding of both human genomics and neurobiology continue to advance, we have a remarkable opportunity to change the way we discover and develop new drugs. Verge has the right people, the right science, and the right culture to shift the paradigm to deliver treatments faster to patients that need them now. I am thrilled to be working with Alice and her exceptional team to help realize the transformative potential of Verge’s platform.”

Dr. Rhodes holds a doctorate in neuropharmacology from the University of Manchester and an M.B.A. from Babson College. In addition to these credentials, she is a sponsor and advocate at the Arlington Academy of Hope, which partners with communities in rural Uganda.

Dr. Rhodes joins Verge Genomics during a period of significant productivity having progressed the lead program from target ID to lead optimization in less than 18 months, and built a robust pipeline in multiple diseases. The company aims to expand its preclinical pipeline and to pursue strategic partnerships towards its goal of developing new medicines for patients in need.

About Verge Genomics:

Verge Genomics is a next-generation biopharmaceutical company that uses machine learning algorithms on patient data to develop new drugs for CNS diseases. Instead of focusing on one gene, their platform surveys hundreds of genes to find new, better intervention points. Their vision is to build an “all-in-human” therapeutics engine that will deliver treatments for neurological diseases with high unmet needs including Alzheimer’s Disease, Parkinson’s Disease, and ALS. Verge Genomics was launched in 2018 with a Series A of $32M funded by DFJ, WuXi AppTec, ALS Investment Fund, and Agent Capital.

Verge Genomics is headquartered in South San Francisco. Learn more at vergegenomics.com or connect on Twitter or LinkedIn.

Share article on social media or email:



Source link

Day for Tomorrow Launches September 22 as Parallel to Earth Day or “People Day”


https://www.prweb.com/

Day for Tomorrow Poster

Day for Tomorrow, a parallel to Earth Day or “People Day” will launch September 22 with events at the Mall in Washington, DC around the country and the world. People with disabilities, the elderly, and on the frontline are disproportionately impacted during disasters and are ignored with respect to climate change. Day for Tomorrow focuses on climate justice and taking action now in community. People are encouraged to join the gathering in DC or meet their neighbors on this day in order to know those next door who have disabilities or are elderly so they can assist them in a disaster. Individuals are encouraged to learn about the climate emergency and take action by not driving, eating vegetarian or turning off the lights for some or all of the day. Communities can hold educational events or other activities in order to promote climate justice.

Day for Tomorrow is necessary because people with disabilities are actively impacted now by climate change. Persons with spinal cord disorders cannot control their body temperature and are forced to stay indoors during extreme heat or cold. During disasters, persons with disabilities and the elderly are most vulnerable, being unable to go to shelters with wheelchairs or personal care assistants. Inadequate accommodations are also available for persons with head injuries and autism who cannot tolerate large open areas with many people.

Marcalee and Craig Alexander left their jobs as a rehabilitation physician and psychologist to launch Day for Tomorrow. Thus far, since June, they have walked from Canada to Atlantic city, evaluating roads for sidewalks, searching for persons with visible disabilities and visiting cities to have some parts underwater by 2060. “We have only seen 11 people in wheelchairs on the road. Sidewalks are only there in towns and in front of commercial establishments. We need to change this as the US moves forward in to conquer the climate emergency. More walking will help American’s physical and mental health”.

The Alexander’s overall goal is to bring attention to the issues of persons with disabilities pertaining to climate change and extreme weather. They have spoken at medical schools and facilitated community events such as a climate justice walk in New York. Their next stops are Atlantic City, Brigantine, Ventor City, Margate City and Ocean City, all deemed to be partly underwater by 2060 by the Wall Street Journal. Next, they are walking to Philadelphia where there will be a walk/roll from Sidney Kimmel Medical College to Love Park on September 8th.

“The earth will always be here, albeit uninhabitable. During this sixth mass extinction, we need to be concerned about people, especially those with disabilities, the elderly and others on the front line. Every person needs to take action as individuals and in community to be prepared for disasters such as hurricanes or floods. The climate emergency is a human justice issue that we need to address now.”

“The face of the climate change in the US must change from Polar Bears and people from other countries to include people in our communities of all ages, colors and abilities. The climate crisis is here and your grandmothers and neighbors. If you do not have a disability now, you are likely to have one in 20-30 years when the impact of climate change is worse. This is everyone’s problem and we all need to get our heads out of the sand and work to conquer it. Come join us on Day for Tomorrow and take action”

For further information contact, Marcalee Alexander at canadatokeywest@gmail.com or 775-343-9322.

Canadatokeywest.org

Share article on social media or email:



Source link

Reflect on Frank Boudreau’s New Book for Devotional Style Leadership Advice


News Image

“If you want maximum results from your leadership…put forth maximum effort as a leader. That doesn’t mean you do all of your team’s work yourself, but it does mean that you will have to do all the things a great leader has to do…. If you want to be your best, you have to give your best.”

Frank Boudreau’s latest work, Everyday Leader: Priceless Leadership Principles That Connect to Everyday Life for the Everyday Leader, shares different pieces of advice for leaders in all fields and levels of experience. From company managers and politicians to educators and parents, being a leader is an aspiration that comes with opportunities to learn and improve oneself alongside the people being led. The author tells us that being an effective leader requires the ability to properly connect with people, to have empathy towards others as everyone is different and has varying needs, the courage to take that first step, and the willingness to set an example for the followers.

“It takes effort, work, and sacrifice to grow as a leader. If you want maximum results from your leadership, you have to put forth maximum effort as a leader,” Frank Boudreau emphasizes that, like all endeavors, leading others is not something that comes easily or immediately. “That doesn’t mean you do all of your team’s work yourself, but it does mean that you will have to do all the things a great leader has to do. Ultimately you will get what you pay for. You will reap what you sow. If you want to be your best, you have to give your best.”

The author also advises that a way to improve one’s leadership skills is through learning how to serve others, particularly those a person leads. As followers, they will look up to their leader for guidance in different situations and value the leader’s opinion depending on how much they trust and respect their leader. If one commits to being a servant-leader, it will inspire their followers to serve others as well. When that happens, a leader and their team will be capable of even greater feats, and this will bring their group even closer together.

Leaders, no matter how experienced, also need a good counsel—someone who will bless them with words that they need to hear so they can make the right decision in a given situation. “I’ve heard some say, ‘I seek counsel in the Lord and that’s all the counsel I need,’ but I think it is important to know that the Lord often provides that counsel through people He places in our lives,” the author tells us that, although the Lord can guide us through miracles, He typically guides us through the people He brings into our lives. “Walking through this life alone with no counsel is a dangerous and lonely thing…. And if you are a believer in the Lord, ask Him to help you recognize the ones He has placed in your life for directing you where you need to go.”

Share article on social media or email:



Source link

Proactive Worldwide Will Share Perspectives on “Social Media Monitoring and Analysis of Medical Conferences” at Pharma CI Conference September 2019


About the Session

Medical conferences provided by health care professionals and researchers have become more visible to the public than ever through the rise of online social media platforms. The internet gives an outlet for individuals to see new information that researchers provide and express thoughts and ideas about that information within the public eye.

Derdowski proposes that pharmaceutical companies can take advantage of the social media phenomenon for the betterment of the medical industry and communities everywhere. By using services to collect and analyze relevant social media data, industry leaders can learn more about reactions and influences of specific information along with the topics that users share and debate the most. Derdowski will then discuss the ways that companies can incorporate these strategies and make them effective tools for improving the industry.

Derdowski has an extensive education in multiple disciplines, including a Ph.D. in Microbiology and Immunology as well as a background in university teaching and experience with scientific and medical writing. As an expert on research and client management for pharmaceutical companies with a variety of projects on his resume, he has the background to help him understand and discuss medical and pharmaceutical strategies.

This Year’s Pharma CI Conference

Derdowski’s presentation will be one of many held during the three days of this year’s Pharma CI USA Conference. This event is the largest annual conference and exhibition for competitive intelligence issues and developments facing the pharmaceutical industry today. Making room for the voices of a diverse group of international companies, the Pharma CI Conference is a place for these company representatives to meet and share ideas over sessions, workshops and networking events.

Dozens of informative insights on the latest competitive strategies in pharmaceuticals this year will strengthen the industry and help leaders make more effective business choices.

Working With Proactive Worldwide

Proactive Worldwide is a consulting firm for research and business strategy development with over 25 years of experience behind it. With clients leading many different types of industries, Proactive Worldwide offers services in scenario planning, competitive response modeling and more, based on insights and evidence gathered by the company.

At the Pharma CI Conference, the company will discuss the power of online tools to gather information about consumers. Proactive Worldwide representatives such as Derdowski make it possible for clients all over the world to market and serve individuals and communities with more effective technologies, predictions and planning. Contact us today for more information about our experience with competitive intelligence and strategic planning.

Share article on social media or email:



Source link

Brian Grant Foundation Launches Team Grant Online Exercise Community for Parkinson’s


The Brian Grant Foundation (BGF) has launched Team Grant, an easy-to-use online tool that allows people with Parkinson’s disease (PD) to set fitness goals, track their exercise activities, earn badges for working out, and connect with others in the PD community.

At team-grant.briangrant.org, Team Grant members can create a profile where they can set fitness goals, track their exercise activity and monitor their progress. Each time a Team Grant member logs an activity on their profile, they are one step closer to earning a fun fitness badge. Users can also integrate their Team Grant fitness activity with a Fitbit wearable device.

Members of Team Grant will receive the latest information about managing Parkinson’s symptoms through diet and exercise, including fitness and nutrition tips, interviews with experts, profiles of people in the Parkinson’s community, and more. They’ll also get updates from BGF founder Brian Grant, a former National Basketball Association player who was diagnosed with young onset Parkinson’s in 2008.

“Playing in the NBA taught me about accountability to my teammates,” said Brian Grant. “Together, we were able to overcome great odds. I believe Team Grant can build that same culture for the Parkinson’s community so that we can live our lives to the fullest.”

Team Grant is based on a former project of BGF and the World Parkinson Congress (WPC), called the Power Through Project, which was a marketing campaign for the WPC in September 2016. Power Through Project users formed teams to track their activity on a web-based map from Montreal, the site of the WPC 2013 to Portland, the site of the WPC 2016. The success of the Power Through Project campaign inspired the recently launched Team Grant network, where users can now set their own individual fitness goals and track their success toward achieving them.

Parkinson’s is a neurodegenerative disorder that affects cells in the brain that produce dopamine, a chemical messenger that helps to control movement. The outward signs of Parkinson’s may include tremors, slowness of movement, balance problems and rigidity. Though there is no cure for Parkinson’s, research has shown that physical activity, healthy eating and social connections are important aspects for managing the condition and improving quality of life with the disease.

About Brian Grant Foundation

Founded in 2010, the Brian Grant Foundation (BGF) provides proven tools to improve the well-being of people with Parkinson’s. BGF’s efforts focus on wellness, specifically exercise, nutrition, and emotional health programs. Visit http://www.briangrant.org to learn more.

Share article on social media or email:



Source link

Implementation, Impact, and Updating of Rapid Blood Culture Identification System in a Community Hospital Network, Upcoming Webinar Hosted by Xtalks


https://www.prweb.com/

Xtalks Life Science Webinars

Bloodstream infections (BSI) leading to sepsis are among the top 10 causes of mortality in the US. However, patients may not receive the most targeted therapy in time because traditional microbiological methods for pathogen detection require days to complete. Rapid molecular detection of these pathogens has shown improvement in patient outcomes, but not all molecular panels have a broad-based coverage of pathogens causing BSI.

Rapid molecular testing for positive blood cultures was introduced to better serve the patient population with potentially life-threatening BSI. The goal was to ensure that patients received the best care, as soon as possible. Delivering faster results can assist in antimicrobial stewardship utilization of the right drug, with the right dose, at the right time. Now that broader panels are available for use, implementation of a new set of rapid molecular panels for detection of more organisms causing BSI can further drive additional positive outcomes in this very important population of patients.

On Friday, September 27, 2019 at 12pm EDT (5pm BST/UK), Kevin M. McNabb, PhD, MT, Director of Microbiology, Immunology and Molecular Testing at New Hanover Regional Medical Center will lead a free webinar to review the data collected from the last five years to current date. He will show how moving from traditional microbiology methods to rapid molecular technology, and then furthermore to a molecular technology with broader coverage, surpassed expectations in many ways while highlighting some of the common challenges and solutions associated with the moving from conventional methods to rapid molecular technologies.

Other topics of discussion include:

  • An overview of the implementation process for rapid molecular testing methods for pathogen identification in bloodstream infections from conventional microbiology methods in a community hospital network
  • A cost justification for adoption of more expensive molecular testing methods over traditional microbiology methods
  • The benefits of implementing a rapid molecular diagnostic test for blood culture identification including better antibiotic stewardship, improved patient outcomes and potential reductions in length of stay
  • Why broader inclusivity of pathogen detection is critical and how to justify making a switch to a different molecular method
  • Reporting of antimicrobial resistance genes to aid medical staff in providing appropriate therapy to patients faster


For more information or to register for this free event, visit Implementation, Impact, and Updating of Rapid Blood Culture Identification System in a Community Hospital Network.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/.

Share article on social media or email:



Source link

How to Reduce Your Regulatory Risk in the Renaissance of Hemp-Derived “Ceutical” Products, Upcoming Webinar Hosted by Xtalks


https://www.prweb.com/

Xtalks Life Science Webinars

In preclinical studies, CBD shows potential therapeutic efficacy against a diverse array of clinical conditions, yet there are major research gaps in our understanding of CBD efficacy for most medical conditions touted in marketing.

With recent regulatory changes to state and national laws, cannabis is undergoing a period of rediscovery and attraction from big pharma, nutraceutical manufacturers, food companies, and retailers.

Chronic CBD users represent 7 percent of the American population, and North American use rates are expected to rise as access to hemp-derived CBD food products increases. In preclinical studies, CBD shows potential therapeutic efficacy against a diverse array of clinical conditions, yet there are major research gaps in our understanding of CBD efficacy for most medical conditions touted in marketing.

Food and dietary supplement contract manufacturers and own label distributors are responsible for knowing the No Observed Adverse Effect Level (NOAEL) which can be learned from clinical studies of the test article. The road to regulatory approval by regulators such as the US Food and Drug Administration (FDA) and Health Canada features safety assessments from preclinical rodent testing, clinical trials, New Dietary Ingredient notifications (NDINs), licensing agreements and more.

In this free webinar, experts from KGK Science will help regulatory personnel, senior level executives, contract manufacturers and food toxicologists navigate this complicated process. The live session with Chief Science Officer Mal Evans, DVM, PhD and Chief Regulatory Officer Corey Hilmas, MD, PhD will take place on Wednesday, September 25, 2019 at 1pm EDT. The presentation will be followed by a live Q&A period.

Specific learning objectives include:


  • CBD research and ideas to substantiate claims for your board room discussion
  • Critical safety components in clinical trials for CBD essential oil for FDA regulators
  • How to reduce your regulatory risk with food safety dossiers
  • How to craft sufficiently qualified, limited-in-scope structure function claims
  • Creating non-disease endpoints in clinical trials for substantiating structure function claims
  • How FDA evaluates dietary ingredient and supplement product safety from a former federal regulator
  • FDA and FTC requirements to meet compliance
  • Best-in-class practices adopted by large corporations to manage risk

For more information or to register for this free event, visit How to Reduce Your Regulatory Risk in the Renaissance of Hemp-Derived “Ceutical” Products.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends, and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:



Source link

Press Release News Wire Service